HIV診断の世界市場規模・シェア・開発・成長・需要予測(~2023年):商品別(消耗品、器具、ソフトウェア・サービス)・検査タイプ別(抗体検査、ウイルス量検査、CD4、早期乳児診断(EID)検査、ウイルス同定検査)・エンドユーザー別(診断研究所、病院、研究機関、その他)の産業インサイト

P&S Market Researchが発行した調査報告書(PSM802071)
◆英語タイトル:Global HIV Diagnosis Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insights by Product (Consumables, Instruments and Software & Services), by Type of Test (Antibody Test, Viral Load, CD4, Early Infant Diagnosis and Viral Identification), by End User (Diagnostic Laboratories, Hospitals, Research Institutes and Others)
◆商品コード:PSM802071
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2017年7月1日
◆ページ数:150
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,100 ⇒換算¥576,300見積依頼/購入/質問フォーム
Group License(5名様閲覧用)USD6,100 ⇒換算¥689,300見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,100 ⇒換算¥1,028,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はP&S Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。P&S Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

According to the study, the global HIV diagnosis market is likely to grow significantly during the forecast period, due to rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits. In addition, rising healthcare expenditure on HIV and related activities further contributes to the growth of the overall market. High cost of automated HIV diagnosis procedures and lack of skilled professionals are some of the key factors restraining the growth of global HIV diagnosis market.
Insights on market segments

As per the findings of the research, based on products, consumables segment is the largest product category in the global HIV diagnosis market. Antibody test has been the largely performed test of the global HIV diagnosis market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.

North America stands as the largest HIV diagnosis market

Geographically, North America has been the largest market for HIV diagnosis, with the U.S. being the largest contributor to the regional market. Increasing prevalence of HIV/AIDS and advantageous features of point of care instruments and kits have been driving the growth of the North American market. In Europe, the U.K. has been the largest contributor to the market for HIV diagnosis, followed by Germany and France. The HIV diagnosis market is expected to witness the fastest growth in Asia-Pacific, during 2017 – 2023, owing to increasing cases of HIV, rising healthcare expenditure and increasing frequency of blood transfusions.

Increasing healthcare expenditure on HIV and related activites largely impacts the market

The healthcare expenditure for the purpose of alleviating the potential epidemic situation of HIV, has increased over the past few years in many low and middle income as well as developing countries. According to the data published by UNAIDS, $19.0 billion was spent on the HIV and AIDS related activities in low- and middle-income countries in 2015, of which 57% came from domestic budgets of the governments of these countries. Considering the increasing incidence of HIV, the UNAIDS estimated that approximately $26.2 billion will be required to respond to the epidemic of HIV infection expected in 2020 and around $23.9 billion will be required for the same, in 2030. The variation in healthcare spending across regions is thought to be related to the relative burden of the disease in that region, which in case of Sub-Saharan Africa is significantly high. The overall healthcare spending on HIV and related activities has increased over the years, which in turn is expected to drive the growth of the global HIV diagnosis market.

Increase in the popularity of home-based HIV diagnosis devices present opportunity to the players in HIV diagnosis market

In recent years the USFDA has approved some home-based HIV diagnosis kits that can provide a HIV test result within 20 to 40 minutes, without having the need for sending the test sample to a laboratory. The home-based HIV diagnosis devices offer a number of advantages over the standard HIV diagnosis procedure since they are more convenient to use, save time and are less costly which has made them increasingly popular in countries such as the U.S. and the U.K. The availability of the home-based tests is expected to contribute significantly in helping more infected people become aware of their HIV status and thereby tapping the untapped potential of HIV diagnosis market. Some of the home-based kits approved by the USFDA include Home Access HIV-1 Test System and OraQuick In-Home HIV Test. This provides an opportunity to the players to further strengthen their current and potential markets, launching low-cost and easy to use HIV diagnosis devices that can be used at home by the consumers.

Key players in the HIV diagnosis market

Some of the key players in the global HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.

【レポートの目次】

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Type of Test

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participants

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Market Breakdown and Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Introduction

3.1 Market Segmentation

3.1.1 Overview by Product

3.1.1.1 Consumables

3.1.1.1.1 Assays, kits & reagents

3.1.1.1.2 Others

3.1.1.2 Instruments

3.1.1.3 Software and services

3.1.2 Overview by Type of Test

3.1.2.1 Antibody test

3.1.2.1.1 HIV-1 screening test

3.1.2.1.1.1 ELISA

3.1.2.1.1.2 Rapid test

3.1.2.1.1.3 Home access dried blood spot

3.1.2.1.2 HIV-1 antibody confirmatory test

3.1.2.1.2.1 Western blot test

3.1.2.1.2.2 IFA

3.1.2.1.2.3 LIA

3.1.2.1.2.4 RIPA

3.1.2.1.3 HIV-2 & group O test

3.1.2.2 Viral load

3.1.2.3 CD4

3.1.2.4 Early infant diagnosis

3.1.2.5 Viral identification

3.1.3 Overview by End User

3.1.3.1 Diagnostic laboratories

3.1.3.2 Hospitals

3.1.3.3 Research institutes

3.1.3.4 Others

3.2 Market Dynamics

3.2.1 Drivers

3.2.1.1 Rising prevalence of HIV/AIDS

3.2.1.2 Growing awareness leading to high number of blood donations and blood transfusions

3.2.1.3 Advantageous features of point of care instruments and kits

3.2.1.4 Rising healthcare expenditure on HIV and related activities

3.2.1.5 Impact analysis of drivers on market forecast

3.2.2 Restraints

3.2.2.1 High cost of automated HIV diagnosis procedures

3.2.2.2 Lack of skilled professionals

3.2.2.3 Impact analysis of restraints on market forecast

3.2.3 Opportunities

3.2.3.1 Growing HIV diagnosis market in emerging economies

3.2.3.2 Increase in the popularity of home-based HIV diagnosis devices

3.3 Porter’s Five Forces Analysis

3.3.1 Bargaining Power of Buyers

3.3.2 Bargaining Power of Suppliers

3.3.3 Threat of New Entrants

3.3.4 Intensity of Rivalry

3.3.5 Threat of Substitutes

Chapter 4. Market Size and Forecast by Product

4.1 Global HIV Diagnosis Consumables Market

4.1.1 Global HIV Diagnosis Consumables Market, by Type

4.1.2 Global HIV Diagnosis Consumables Market, by Region

4.2 Global HIV Diagnosis Instruments Market

4.2.1 Global HIV Diagnosis Instruments Market, by Region

4.3 Global HIV Diagnosis Software & Services Market

4.3.1 Global HIV Diagnosis Software & Services Market, by Region

Chapter 5. Market Size and Forecast by Type of Test

5.1 Global HIV Diagnosis Antibody Test Market

5.1.1 Global HIV Diagnosis Antibody Test Market, By Type

5.1.1.1 Global HIV-1 screening test market

5.1.1.1.1 Global HIV-1 screening test market, by type

5.1.1.2 Global HIV-1 antibody confirmatory test market

5.1.1.2.1 Global HIV-1 antibody confirmatory test market, by type

5.1.2 Global HIV Diagnosis Antibody Test Market, by Region

5.2 Global HIV Diagnosis Viral Load Test Market

5.2.1 Global HIV Diagnosis Viral Load Test Market, by Region

5.3 Global HIV Diagnosis CD4 Test Market

5.3.1 Global HIV Diagnosis CD4 Test Market, by Region

5.4 Global Early Infant Diagnosis Test Market

5.4.1 Global Early Infant Diagnosis Test Market, by Region

5.5 Global Viral Identification Test Market

5.5.1 Global Viral Identification Test Market, by Region

Chapter 6. Market Size and Forecast by End User

6.1 Global HIV Diagnosis Market for Diagnostic Laboratories

6.1.1 Global HIV Diagnosis Market for Diagnostic Laboratories, by Region

6.2 Global HIV Diagnosis Market for Hospitals

6.2.1 Global HIV Diagnosis Market for Hospitals, by Region

6.3 Global HIV Diagnosis Market for Research Institutes

6.3.1 Global HIV Diagnosis Market for Research Institutes, by Region

Chapter 7. Market Size and Forecast by Geography

7.1 North America HIV Diagnosis Market

7.1.1 North America HIV Diagnosis Market, by Product

7.1.2 North America HIV Diagnosis Market, by Type of Test

7.1.3 North America HIV Diagnosis Market, by End User

7.1.4 North America HIV Diagnosis Market, by Country

7.2 Europe HIV Diagnosis Market

7.2.1 Europe HIV Diagnosis Market, by Product

7.2.2 Europe HIV Diagnosis Market, by Type of Test

7.2.3 Europe HIV Diagnosis Market, by End User

7.2.4 Europe HIV Diagnosis Market, by Country

7.3 Asia-Pacific HIV Diagnosis Market

7.3.1 Asia-Pacific HIV Diagnosis Market, by Product

7.3.2 Asia-Pacific HIV Diagnosis Market, by Type of Test

7.3.3 Asia-Pacific HIV Diagnosis Market, by End User

7.3.4 Asia-Pacific HIV Diagnosis Market, by Country

7.4 Latin America HIV Diagnosis Market

7.4.1 Latin America HIV Diagnosis Market, by Product

7.4.2 Latin America HIV Diagnosis Market, by Type of Test

7.4.3 Latin America HIV Diagnosis Market, by End User

7.4.4 Latin America HIV Diagnosis Market, by Country

7.5 Middle East & Africa (MEA) HIV Diagnosis Market

7.5.1 MEA HIV Diagnosis Market, by Product

7.5.2 MEA HIV Diagnosis Market, by Type of Test

7.5.3 MEA HIV Diagnosis Market, by End User

Chapter 8. Competitive Landscape

8.1 Benchmarking of HIV Diagnosis Products by Key Players

8.2 Global Strategic Developments

8.2.1 Merger & Acquisition

8.2.2 Partnership

8.2.3 Product Launch/Approval

8.2.4 Other

Chapter 9. Company Profiles

9.1 Siemen AG

9.1.1 Business Overview

9.1.2 Product and Service Offerings

9.2 Abbott Laboratories

9.2.1 Business Overview

9.2.2 Product and Service Offerings

9.3 Merck KGaA

9.3.1 Business Overview

9.3.2 Product and Service Offerings

9.4 Becton, Dickinson and Company

9.4.1 Business Overview

9.4.2 Product and Service Offerings

9.5 Hologic Inc.

9.5.1 Business Overview

9.5.2 Product and Service Offerings

9.6 F. Hoffmann-La Roche Ltd.

9.6.1 Business Overview

9.6.2 Product and Service Offerings

9.7 Thermo Fisher Scientific Inc.

9.7.1 Business Overview

9.7.2 Product and Service Offerings

9.8 Danaher Corporation

9.8.1 Business Overview

9.8.2 Product and Service Offerings

9.9 Bio-Rad Laboratories, Inc.

9.9.1 Business Overview

9.9.2 Product and Service Offerings

9.10 Alere, Inc.

9.10.1 Business Overview

9.10.2 Product and Service Offerings

Chapter 10. Appendix

10.1 Abbreviations

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 5 GLOBAL HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 6 GLOBAL HIV DIAGNOSIS CONSUMABLES MARKET, BY TYPE, $M (2013 – 2016)

TABLE 7 GLOBAL HIV DIAGNOSIS CONSUMABLES MARKET, BY TYPE, $M (2017 – 2023)

TABLE 8 GLOBAL HIV DIAGNOSIS CONSUMABLES MARKET, BY REGION, $M (2013 – 2016)

TABLE 9 GLOBAL HIV DIAGNOSIS CONSUMABLES MARKET, BY REGION, $M (2017 – 2023)

TABLE 10 GLOBAL HIV DIAGNOSIS INSTRUMENTS MARKET, BY REGION, $M (2013 – 2016)

TABLE 11 GLOBAL HIV DIAGNOSIS INSTRUMENTS MARKET, BY REGION, $M (2017 – 2023)

TABLE 12 GLOBAL HIV DIAGNOSIS SOFTWARE & SERVICES MARKET, BY REGION, $M (2013 – 2016)

TABLE 13 GLOBAL HIV DIAGNOSIS SOFTWARE & SERVICES MARKET, BY REGION, $M (2017 – 2023)

TABLE 14 GLOBAL HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2016)

TABLE 15 GLOBAL HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2017 – 2023)

TABLE 16 GLOBAL HIV DIAGNOSIS ANTIBODY TEST MARKET, BY TYPE, $M (2013 – 2016)

TABLE 17 GLOBAL HIV DIAGNOSIS ANTIBODY TEST MARKET, BY TYPE, $M (2017 – 2023)

TABLE 18 GLOBAL HIV-1 SCREENING TEST MARKET, BY TYPE, $M (2013 – 2016)

TABLE 19 GLOBAL HIV-1 SCREENING TEST MARKET, BY TYPE, $M (2017 – 2023)

TABLE 20 GLOBAL HIV-1 ANTIBODY CONFIRMATORY TEST MARKET, BY TYPE, $M (2013 – 2016)

TABLE 21 GLOBAL HIV-1 ANTIBODY CONFIRMATORY TEST MARKET, BY TYPE, $M (2017 – 2023)

TABLE 22 GLOBAL HIV DIAGNOSIS ANTIBODY TEST MARKET, BY REGION, $M (2013 – 2016)

TABLE 23 GLOBAL HIV DIAGNOSIS ANTIBODY TEST MARKET, BY REGION, $M (2017 – 2023)

TABLE 24 GLOBAL HIV DIAGNOSIS VIRAL LOAD TEST MARKET, BY REGION, $M (2013 – 2016)

TABLE 25 GLOBAL HIV DIAGNOSIS VIRAL LOAD TEST MARKET, BY REGION, $M (2017 – 2023)

TABLE 26 GLOBAL HIV DIAGNOSIS CD4 TEST MARKET, BY REGION, $M (2013 – 2016)

TABLE 27 GLOBAL HIV DIAGNOSIS CD4 TEST MARKET, BY REGION, $M (2017 – 2023)

TABLE 28 GLOBAL EARLY INFANT DIAGNOSIS TEST MARKET, BY REGION, $M (2013 – 2016)

TABLE 29 GLOBAL EARLY INFANT DIAGNOSIS TEST MARKET, BY REGION, $M (2017 – 2023)

TABLE 30 GLOBAL VIRAL IDENTIFICATION TEST MARKET, BY REGION, $M (2013 – 2016)

TABLE 31 GLOBAL VIRAL IDENTIFICATION TEST MARKET, BY REGION, $M (2017 – 2023)

TABLE 32 GLOBAL HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 33 GLOBAL HIV DIAGNOSIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 34 GLOBAL HIV DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2013 – 2016)

TABLE 35 GLOBAL HIV DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2017 – 2023)

TABLE 36 GLOBAL HIV DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, $M (2013 – 2016)

TABLE 37 GLOBAL HIV DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, $M (2017 – 2023)

TABLE 38 GLOBAL HIV DIAGNOSIS MARKET FOR RESEARCH INSTITUTES, BY REGION, $M (2013 – 2016)

TABLE 39 GLOBAL HIV DIAGNOSIS MARKET FOR RESEARCH INSTITUTES, BY REGION, $M (2017 – 2023)

TABLE 40 NORTH AMERICA HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 41 NORTH AMERICA HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 42 NORTH AMERICA HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2016)

TABLE 43 NORTH AMERICA HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2017 – 2023)

TABLE 44 NORTH AMERICA HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 45 NORTH AMERICA HIV DIAGNOSIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 46 NORTH AMERICA HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 47 NORTH AMERICA HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 48 EUROPE HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 49 EUROPE HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 50 EUROPE HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2016)

TABLE 51 EUROPE HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2017 – 2023)

TABLE 52 EUROPE HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 53 EUROPE HIV DIAGNOSIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 54 EUROPE HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 55 EUROPE HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 56 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 57 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 58 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2016)

TABLE 59 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2017 – 2023)

TABLE 60 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 61 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 62 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 63 ASIA-PACIFIC HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 64 LATIN AMERICA HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 65 LATIN AMERICA HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 66 LATIN AMERICA HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2016)

TABLE 67 LATIN AMERICA HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2017 – 2023)

TABLE 68 LATIN AMERICA HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 69 LATIN AMERICA HIV DIAGNOSIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 70 LATIN AMERICA HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 71 LATIN AMERICA HIV DIAGNOSIS MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 72 MEA HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 73 MEA HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 74 MEA HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2016)

TABLE 75 MEA HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2017 – 2023)

TABLE 76 MEA HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 77 MEA HIV DIAGNOSIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 78 SIEMEN AG – AT A GLANCE

TABLE 79 ABBOTT LABORATORIES – AT A GLANCE

TABLE 80 MERCK KGAA – AT A GLANCE

TABLE 81 BECTON, DICKINSON AND COMPANY – AT A GLANCE

TABLE 82 HOLOGIC INC. – AT A GLANCE

TABLE 83 F. HOFFMANN-LA ROCHE LTD. – AT A GLANCE

TABLE 84 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 85 DANAHER CORPORATION – AT A GLANCE

TABLE 86 BIO-RAD LABORATORIES, INC. – AT A GLANCE

TABLE 87 ALERE, INC. – AT A GLANCE

LIST OF FIGURES

FIG 1 RESEARCH SCOPE FOR GLOBAL HIV DIAGNOSIS MARKET

FIG 2 RESEARCH METHODOLOGY FOR THE GLOBAL HIV DIAGNOSIS MARKET

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH FOR THE GLOBAL HIV DIAGNOSIS MARKET

FIG 8 GLOBAL PREVALENCE OF PEOPLE LIVING WITH HIV INFECTION, IN MILLIONS (2011-2015)

FIG 9 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL HIV DIAGNOSIS MARKET

FIG 10 GLOBAL HIV DIAGNOSIS PRODUCTS MARKET SNAPSHOT (2016)

FIG 11 GLOBAL HIV DIAGNOSIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 12 GLOBAL HIV DIAGNOSIS CONSUMABLES MARKET, BY TYPE, $M (2013 – 2023)

FIG 13 GLOBAL HIV DIAGNOSIS CONSUMABLES MARKET, BY REGION, $M (2013 – 2023)

FIG 14 GLOBAL HIV DIAGNOSIS INSTRUMENTS MARKET, BY REGION, $M (2013 – 2023)

FIG 15 GLOBAL HIV DIAGNOSIS SOFTWARE & SERVICES MARKET, BY REGION, $M (2013 – 2023)

FIG 16 GLOBAL HIV DIAGNOSIS MARKET BY TYPE OF TEST SNAPSHOT (2016)

FIG 17 GLOBAL HIV DIAGNOSIS MARKET, BY TYPE OF TEST, $M (2013 – 2023)

FIG 18 GLOBAL HIV DIAGNOSIS ANTIBODY TEST MARKET, BY TYPE, $M (2013 – 2023)

FIG 19 GLOBAL HIV-1 SCREENING TEST MARKET, BY TYPE, $M (2013 – 2023)

FIG 20 GLOBAL HIV-1 ANTIBODY CONFIRMATORY TEST MARKET, BY TYPE, $M (2013 – 2023)

FIG 21 GLOBAL HIV DIAGNOSIS ANTIBODY TEST MARKET, BY REGION, $M (2013 – 2023)

FIG 22 GLOBAL HIV DIAGNOSIS VIRAL LOAD TEST MARKET, BY REGION, $M (2013 – 2023)

FIG 23 GLOBAL HIV DIAGNOSIS CD4 TEST MARKET, BY REGION, $M (2013 – 2023)

FIG 24 GLOBAL EARLY INFANT DIAGNOSIS TEST MARKET, BY REGION, $M (2013 – 2023)

FIG 25 GLOBAL VIRAL IDENTIFICATION TEST MARKET, BY REGION, $M (2013 – 2023)

FIG 26 GLOBAL HIV DIAGNOSIS END USER MARKET SNAPSHOT (2016)

FIG 27 GLOBAL HIV DIAGNOSIS MARKET, BY END USER, $M (2013 – 2023)

FIG 28 GLOBAL HIV DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2013 – 2023)

FIG 29 GLOBAL HIV DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, $M (2013 – 2023)

FIG 30 GLOBAL HIV DIAGNOSIS MARKET FOR RESEARCH INSTITUTES, BY REGION, $M (2013 – 2023)

FIG 31 WORLDWIDE MAJOR MARKETS FOR HIV DIAGNOSIS

FIG 32 NORTH AMERICA HIV DIAGNOSIS MARKET SNAPSHOT

FIG 33 EUROPE HIV DIAGNOSIS MARKET SNAPSHOT

FIG 34 ASIA-PACIFIC HIV DIAGNOSIS MARKET SNAPSHOT

FIG 35 LATIN AMERICA HIV DIAGNOSIS MARKET SNAPSHOT

FIG 36 MEA HIV DIAGNOSIS MARKET SNAPSHOT

FIG 37 BENCHMARKING OF HIV DIAGNOSIS PRODUCTS BY KEY PLAYERS



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ HIV診断の世界市場規模・シェア・開発・成長・需要予測(~2023年):商品別(消耗品、器具、ソフトウェア・サービス)・検査タイプ別(抗体検査、ウイルス量検査、CD4、早期乳児診断(EID)検査、ウイルス同定検査)・エンドユーザー別(診断研究所、病院、研究機関、その他)の産業インサイト(Global HIV Diagnosis Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insights by Product (Consumables, Instruments and Software & Services), by Type of Test (Antibody Test, Viral Load, CD4, Early Infant Diagnosis and Viral Identification), by End User (Diagnostic Laboratories, Hospitals, Research Institutes and Others))]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆